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Abstract
Environmental Enteric Dysfunction (EED) is an acquired small intestinal inflammatory condi-
tion underlying high rates of stunting in children <5 years of age in low- and middle-income
countries. Children with EED are known to have repeated exposures to enteropathogens
and environmental toxins that leads to malabsorptive syndrome. We aimed to characterize
association of linear growth faltering with enteropathogen burden and subsequent changes
in EED biomarkers. In a longitudinal birth cohort (n = 272), monthly anthropometric mea-
surements (Length for Age Z score- LAZ) of asymptomatic children were obtained up to 18
months. Biological samples were collected at 6 and 9 months for the assessment of bio-
markers. A customized TaqMan array card was used to target 40 enteropathogens in fecal
samples. Linear regression was applied to study the effect of specific enteropathogen infec-
tion on change in linear growth (ΔLAZ). Presence of any pathogen in fecal sample corre-
lated with serum flagellin IgA (6 mo, r = 0.19, p = 0.002), fecal Reg 1b (6 mo, r = 0.16, p =
0.01; 9mo, r = 0.16, p = 0.008) and serum Reg 1b (6 mo, r = 0.26, p<0.0001; 9 mo, r = 0.15,
p = 0.008). At 6 months, presence of Campylobacter [β (SE) 7751.2 (2608.5), p = 0.003]
and ETEC LT [β (SE) 7089.2 (3015.04), p = 0.019] was associated with increase in MPO.
Giardia was associated with increase in Reg1b [β (SE) 72.189 (26.394), p = 0.006] and anti-
flic IgA[β (SE) 0.054 (0.021), p = 0.0091]. Multiple enteropathogen infections in early life
negatively correlated with ΔLAZ, and simultaneous changes in gut inflammatory and perme-
ability markers. A combination vaccine targeting enteropathogens in early life could help in
the prevention of future stunting.
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Introduction
Environmental Enteric dysfunction (EED) is a subclinical inflammatory disease of the small
intestine characterized histologically by blunted villi, elongated crypts and increased lympho-
cytic infiltration of the lamina propria [1, 2]. These histological changes are associated with
subsequent malabsorption, impaired cognitive development [3, 4], reduced responsiveness to
nutritional intervention [5], and reduced immunogenicity of oral vaccine [6, 7] in apparently
healthy children [8, 9]. The main impediment in diagnosis of EED is examination of upper
bowel mucosa, which is impractical for a high proportion of children failing nutritional inter-
vention [10]. The role of enteropathogens are well documented in studies such as Etiology,
Risk Factors and Interactions of Enteric Infection and Malnutrition and the Consequences for
Child Health and Development (MAL-ED) and Global Enteric Multicenter Study (GEMS)
[11, 12]. However, asymptomatic enteropathogen carriage in children with EED has not been
studied in detail with growth faltering and change in EED biomarkers. The knowledge of gut
pathobiome in apparently healthy children may be associated with the causal pathway of EED,
which is a multifactorial disease process accompanied by repeated exposure to pathogens and
possible dysbiosis of microbiome during infancy [13]. In developing countries, it is known
that in the absence of diarrhea, 15% of children under five years are infected with ETEC as
asymptomatic carriers [14].
In the current EED cohort, we first examined the relationship of bacterial translocation
marker along with gut and systemic inflammatory biomarkers in children with growth falter-
ing [15]. The presence of IgA against bacterial flagellin and LPS was found to be associated
with enteric inflammation and with subsequent decline in linear growth. In order to explore
the contribution of enteropathogens in EED, we further characterized the association of enter-
opathogen burden with putative biomarkers and subsequent growth faltering at 18 months of
age. We hypothesized that increased enteropathogen burden in the early period of life is asso-
ciated with future decline in LAZ scores and corresponding changes in EED biomarker pro-
files. Identification of any single or a group of enteropathogens could provide early screening
of children who are at risk of developing EED.
Material and methods
Ethics statement
Institutional approval was granted by the Aga Khan University Ethical Review Committee
(ERC# 2446 Ped ERC 13) and the University of Virginia Institutional Review Board. All
parents provided written informed consent for participation of their children in the study.
Study design and participants
Subjects included in this analysis were part of a prospective community-based active surveil-
lance birth cohort and were followed longitudinally for anthropometrics and biomarker mea-
surements, response to Ready-to-Use-Therapeutic-Food (RUTF) and subsequent endoscopic/
histopathological examination in cases of inadequate growth response to RUTF [16, 17]. Addi-
tional descriptive characteristics of the study participants are shown in S1 Table.
Newborns (n = 272) were enrolled and assessed during routine surveillance of pregnant
women of reproductive age (13–49 years) by community health workers (CHWs) [18]. Study
inclusion criteria were: 1) newborns aged up to 14 days; 2) absence of any major congenital
abnormalities and; 3) ability to obtain informed consent from parents or guardians. Infants of
families planning to move out of the study area within 6 months of birth were excluded from
the trial. Enrolled children were followed from birth (0 to 14 days) until 18 months of age with
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weekly home visits during the study period from October 2012 to November 2015 for diarrheal
and acute respiratory infection episodes (S1 Fig). All families enrolled in the study were pro-
vided with cell phone contact information of key study physicians to enable direct and imme-
diate contact in the case of any urgent medical need. Monthly measurements were recorded by
trained Community Health Workers using standard techniques: child’s weight using a digital
infant balance with 20-g precision (TANITA 1584) and child’s length using a rigid length
board with a movable foot piece with 1 mm precision. Standardization of measurements was
ensured through regular staff training and cross checks.
Biological specimen collection
Blood was obtained from enrolled children at 6 and 9 months of age. Samples were centrifuged
in the field site research laboratory and plasma was removed within 2 h of blood collection.
Samples were transported at 4˚C from the field site at Matiari, Pakistan to the Aga Khan Uni-
versity Infectious Disease Research Lab (IDRL) under cold chain maintenance. Aliquots were
stored at -80˚C.
For collection of fecal samples, the mother/care-taker was instructed to use a diaper pro-
vided by the research staff that was lined with a thin plastic sheet to prevent absorption. Defe-
cated samples were collected from the participant’s homes. Using a clean spatula, the fecal
samples were transferred to a clean container. The fecal samples were transported from the
child’s home to a peripheral laboratory in a 15 liter Coleman cooler with cold chain mainte-
nance at 4˚C. The samples were further aliquoted into small vials and were stored in the cen-
tral laboratory IDRL at - 80ºC.
Measurement of biomarkers. Peripheral blood samples were tested for flagellin and LPS-
specific IgA and IgG concentrations measured by ELISA as previously reported [19]. Microti-
ter plates were coated with purified E. coli flagellin (100ng/well) or purified E. coli LPS (2 μg/
well). Serum samples were diluted 1:200 and applied to the coated wells. After incubation and
washing, the wells were incubated with anti-human IgA (KPL) or IgG (GE Healthcare) cou-
pled to horseradish peroxidase. Quantification of total immunoglobulin was performed using
the colorimetric peroxidase substrate tetramethylbenzidine (TMB) and read at 450 nm optical
density (OD) on an ELISA plate reader. Data was reported as OD corrected by subtracting
background levels, which were determined by reading in samples lacking serum. Commercial
ELISA kits were used for the estimation of regenerating gene 1β (Reg 1b) (TechLab, Blacks-
burg, Virginia) in feces and serum. For intestinal inflammation, Myeloperoxidase (MPO) kit
(Immunodiagnostic AG, Stubenwald-Allee, Bensheim) and Neopterin (NEO) (GenWay Bio-
tech, San Diego, CA) were used for fecal samples as reported previously [20]. Biomarkers of
systemic inflammation (C-reactive protein [CRP], alpha- 1-acid glycoprotein [AGP], and ferri-
tin) were analyzed on the Hitachi 902 analyzer (Roche Diagnostics, Holliston, MA). All proto-
cols were followed as per manufacturers’ instruction. The final dilution for serum and fecal
biomarkers was determined by selecting the most appropriate concentration of a biomarker
falling in the linear range of standard curve. Reg 1b was performed in two dilutions of 1:40,000
and 1:100,000, NEO at the dilution of 1:250 and MPO at 1:500. All plates were read on the
Biorad iMark (Hercules, CA) plate reader.
TAC analysis of fecal samples. TaqMan Array card (TAC): The TaqMan low density
array card or TAC allows molecular detection of multiple enteric pathogens using a custom-
ized detection platform based on a real time PCR detection system [21]. The enteric pathogen
panel included viruses, bacteria and helminths. The TAC card was customized to detect micro-
bial pathogens in the fecal samples collected at 6 months (n = 272) and 9 months (n = 271).
This platform has been successfully used in our lab for multicenter studies such as GEMS and
Enteropathogens and linear growth decline in EED
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MAL-ED [22, 23]. Briefly, total nucleic acid (TNA) was extracted from approximately 180-
220g of fecal samples using the bead beating method by adding 370mg of glass beads (Sigma,
Aldrich, UK) followed by TNA extraction using QIAmp DNA Stool MiniKit (Qiagen,German-
town, MD). As per protocol, all samples were spiked with internal controls of PhHV (Phocine
Herpes Virus) and MS2 (MS2 bacteriophage) as DNA and RNA targets respectively for valida-
tion of samples and to check the efficiency of extraction, reverse transcription and amplifica-
tion steps. The TAC protocol was modified from the Next Generation Molecular Diagnostic
project (Houpt Lab, University of Virginia, Charlottesville, USA). 100μl of TNA was eluted
from the DNA extraction kit. Of this, 40 μl was mixed with 60μl of AgPath one step RT-PCR
kit (Ambion, Applied Biosystem) and 100μl was loaded on a TAC card through microfluidic
ports. The card was sealed and processed on ViiA7 (Applied Bio systems, Thermofisher, USA).
A total of 8 samples were run in a single card along with extraction blank (consisting of nucle-
ase free water with PhHV & MS2) and PCR blank (consisting of nuclease free water only). The
samples were considered valid positive if target Ct value was less than 32, reference extraction
blank was negative for target and internal control, and MS2 had Ct value less than 38.
These TAC cards were customized to detect 40 common enteropathogens including the fol-
lowing: Adenovirus, Aeromonas, Ancylostoma, Ascaris, Astrovirus, Bacteroides fragilis, Cam-
pylobacter jejuni and Campylobacter coli, Clostridium difficile, Cryptosporidium hominis and
Cryptosporidium parvum, Cyclospora, Encephalitozoon intestinalis, Entamoeba histolytica,
Enterocytozoon bieneusi, enteroaggregative Escherichia coli (EAEC), enteroinvasive E. coli
(EIEC), enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), shigatoxigenic sero-
types of E. coli (STEC), enterovirus, Giardia, Helicobacter pylori, Isospora, Mycobacterium
tuberculosis, Necator, norovirus, rotavirus, Salmonella, sapovirus, Shigella, Strongyloides, Tri-
churis, and Vibrio cholerae.
Statistical analysis
WHO Child Growth Standards (WHO Anthro, Geneva, Switzerland) [24] was used to calcu-
late z-scores and assess growth both as continuous measures [length-for-age z-score (LAZ),
weight-for-age z-score (WAZ) and weight-for-height z-score (WHZ)] and as categorized vari-
ables of stunting [LAZ< −2 SD (standard deviation), underweight as WAZ< −2 SD and wast-
ing as WHZ< −2 SD]. In accordance with WHO recommendations, we excluded outliers of
LAZ (<-6 or>6), WHZ (<-5 or >5), and WAZ (<-6 or >5) [25].
Effect of specific enteropathogen infection on children’s length over time was measured by
using delta LAZ, a change in length-for-age (ΔLAZ = 18months-birth). The relationship
between the change in z-scores (LAZ/WAZ/WHZ) and infection with specific pathogens at 6
and 9 months was modeled via simple linear regression to examine the unadjusted association
of enteric infection (categorical variable, either yes or no for each pathogen) with the continu-
ous outcome of change in LAZ score from birth to 18 months. Linear regression was used to
further evaluate the association between ΔLAZ (dependent variable) with specific pathogens
infection (independent variables), adjusting for antibiotics use:
Model 1 : DLAZ ¼ b0 þ b1 pathogenþ b2antibioticsþ ε
Where β is the estimated regression coefficient, ε is the error term, “pathogen” (categorical
variable) refers to whether or not each specific pathogen has infected a given child (a different
term for each pathogen in the model), and “antibiotics” (categorical variable) refers to the use
of antibiotic at least once during the period of 6 or 9 months as “Yes”. Our approach was
informed by a hypothesized conceptual causal diagram (Fig 1) for EED determinants. Correla-
tions were calculated using Pearson correlation coefficient with associated 95% confidence
Enteropathogens and linear growth decline in EED
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between positive counts of pathogens (continuous variable) and ΔLAZ. Similar correlations
were calculated between positive counts of pathogens (continuous variable) and our biomark-
ers of systemic inflammation (CRP, AGP, ferritin), enteric inflammation and intestinal regen-
eration (MPO, NEO, Reg 1b feces and serum), and bacterial translocation (anti-flic and anti-
LPS IgA and IgG).
Biomarkers found to be significantly correlated with increasing pathogen counts were
taken as part of a sub-analysis in which we used linear regression models at 6 months (anti-flic
IgA, MPO, Reg 1b feces and serum) and 9 months (CRP, AGP, Reg 1b feces and serum) with
each biomarker as the dependent variable and infection with specific pathogens as indepen-
dent variables (categorical variable) with antibiotic use included as a covariate:
Model 2 : Biomarker
¼ b0 þ b1 pathogen1 þ b2pathogen2 þ . . .þ bkpathogenk þ bkþ1antibioticsþ ε
Where β is the estimated regression coefficient, ε is the error term, “pathogenk” (categorical
variable) refers to whether or not each specific pathogen has infected a given child (a different
term for each pathogen in the model), and “antibiotics” (categorical variable) refers to the use
of antibiotics at 6 and 9 months. This multivariable analysis was performed for each bio-
marker. All analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC, USA).
Results
Impact of enteropathogens burden on LAZ
Table 1 shows the proportions of children infected with different pathogen subtypes and their
respective mean LAZ scores. In each category of enteropathogen that included bacteria, viruses
Fig 1. Hypothesized causal pathways for environmental enteric dysfunction (EED). Analyses included factors highlighted in blue in order to
model the relationship between fecal enteropathogens and markers of bacterial translocation, inflammatory biomarkers with growth faltering in
association with EED.
https://doi.org/10.1371/journal.pone.0221095.g001
Enteropathogens and linear growth decline in EED
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and protozoa, no difference was found in the mean LAZ score in children with or without par-
ticular infection. This trend was similar at both 6 and 9 months.
Association of enteropathogen counts with ΔLAZ score and inflammatory
biomarkers
Overall, the frequency of bacterial infection was found to be similar in the samples collected at
6 and 9 months with the exception of Campylobacter and Cryptosporidium. Among viral and
protozoal pathogens, Adenovirus, Sapovirus, Giardia and Cryptosporidium frequencies were
higher at 9 months compared to 6 months (S2 Fig)
Table 2 shows correlation coefficients between growth and enteropathogen burden. There
was a significant negative correlation between enteropathogen counts of all subtypes at 6
months and ΔLAZ (18 months-birth). This effect was no longer significant at 9 months. We
further analyzed positive counts of enteropathogen with putative EED biomarkers. Presence of
enteropathogen (all positive for bacteria, virus, protozoa) correlated with serum flagellin (flic)
IgA, fecal Reg 1b and serum Reg 1b. Infection with bacteria correlated with MPO, protozoa
with CRP, AGP and Ferritin, while viral infection with CRP.
Infection with enteropathogens is associated with change in LAZ score
Table 3 shows the association of ΔLAZ(18month-birth) with specific enteropathogen at 6 and 9
months of age. We found a nominally significant decline in LAZ with the positivity of Astro-
virus, Campylobacter, Cryptosporidium and Giardia at 6 months (nominal p-value < 0.05).
The effects of these enteropathogens on ΔLAZ became insignificant at threshold of 0.05 after
the adjustment for false discovery rate (FDR). Nevertheless, Campylobacter, Cryptosporidium
and Giardia were marginally associated with ΔLAZ at FDR threshold of 0.1. There was mini-
mal or no change in delta LAZ for the given pathogens at 9 months compared to those at 6
months after FDR adjustment, even if Norovirus at 9 months was significantly associated with
ΔLAZ at nominal significance level.
Infection with specific enteropathogens is associated with an increase in
inflammatory biomarkers
In order to analyze the effect of enteropathogen infection on inflammatory biomarkers, we
selected biomarkers based on their significant correlation with increasing enteropathogen
count (Table 2). The significant associations at 6 months included anti-flic IgA with astrovirus
Table 1. Characteristics of the Pakistani cohort at 6 months (N = 272) and 9 months (N = 271) with regards to pathogen infection and length-for-age Z (LAZ)
scores.
Enteropathogens at 6 months Enteropathogens at 9 months
Bacteria Protozoa Viruses Bacteria Protozoa Viruses
Yes No p¥ Yes No p¥ Yes No p¥ Yes No p¥ Yes No p¥ Yes No p¥
N (%) 247
(90.1)
27(9.9) 0.93 137
(50.0)
137
(50.0)
0.70 249
(92.9)
25 (7.1) 0.099 256
(93.8)
17(6.2) 0.098 194
(71.1)
79
(28.9)
0.42 253
(92.7)
20(7.3) 0.35
LAZ
Mean
(SD)
-2.73
(1.08)
-2.70
(1.67)
-2.75
(1.15)
-2.70
(1.14)
-2.69
(1.16)
-3.09
(0.90)
-2.76
(1.15)
-2.28
(0.97)
-2.77
(1.18)
-2.64
(1.05)
-2.75
(1.16)
-2.50
(0.87)
Notes: “Yes” = infection with 1 or more pathogens of the specified category. “No” = no infections of the specified category. LAZ18 = length-for-age Z score at the 18th
months of life. None of the differences in LAZ score between children infected or not infected with pathogens of a given category were significant. p¥ (p-value) refers to
the difference between mean LAZ scores at 18 months of age in the groups positive and negative for enteropathogens at 6 or 9 months.
https://doi.org/10.1371/journal.pone.0221095.t001
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infection, anti-flic IgA with STEC (stx1, stx2) infection, MPO with Campylobacter infection,
serum Reg 1b with ETEC ST infection, fecal Reg1 β with Giardia (Table 4). At 9 months, only
serum Reg 1b reported significant correlation with Campylobacter infection (S2 Table).
Discussion
In the context of EED, the present study highlights the association between enteropathogens
and linear growth–an association hypothesized to be mediated through enteric and systemic
inflammatory pathway [15]. The key findings of our study are: a) the presence of at least one
enteropathogen in fecal samples at 6 and 9 months of age (Table 1) (at least one bacteria, one
protozoa and one virus); b) a negative correlation of delta LAZ with observed pathogen at 6
months (Table 2); and c) an association of specific enteropathogens with positive or negative
changes in beta estimates of EED biomarkers as outcome variable.
Overall we found that subclinical infection with entropathogen was marginally associated
with linear growth. The presence of similar pathogens such as Giardia, Campylobacter and
Cryptosporidium also showed substantial negative association in MAL-ED cohort [26].
Table 2. Correlation coefficient matrix of biomarkers¥ and the change in Z scores for length over the first 18 months of life with the number of enteropathogens
infecting children at 6 and 9 months.
Enteropathogens at 6 months Enteropathogens at 9 months
Counts of All
Positive Pathogens
Counts of
Positive
Bacteria
Counts of
Positive
Protozoa
Counts of
Positive
Viruses
Counts of
All Positive
Pathogens
Counts of
Positive
Bacteria
Counts of
Positive
Protozoa
Counts of
Positive
Viruses
Growth ΔLAZ -0.21� -0.12 -0.15� -0.15� -0.062 -0.017 -0.036 -0.075
Bacterial
Translocation
Anti-LPS
IgA, OD
0.098 0.04 0.077 0.091 -0.0078 -0.046 -0.013 0.067
Anti-LPS
IgG, OD
0.036 0.09 -0.049 -0.0095 -0.030 0.011 -0.041 -0.043
Anti-flic IgA,
OD
0.19� -0.0017 0.22�� 0.23�� 0.0026 -0.055 0.013 0.078
Anti-flic IgG,
OD
0.039 0.051 0.012 -0.0053 -0.052 -0.056 -0.048 0.019
Systemic Inflammation CRP, mg/L 0.085 0.11 0.0072 0.011 0.066 0.075 0.16� -0.13�
AGP, mg/dL 0.018 0.040 0.016 -0.039 0.088 0.029 0.18� -0.030
Ferritin, ng/
mL
-0.093 -0.11 0.069 -0.10 0.061 -0.036 0.19� 0.0066
Enteric inflammation
& regeneration
MPO, ng/mL 0.083 0.15� 0.024 -0.076 0.045 0.020 0.042 0.028
NEO, nmol/L 0.024 -0.015 0.013 0.067 -0.075 -0.057 -0.099 0.018
Reg 1b
Serum, ng/
mL
0.26��� 0.28��� 0.12� 0.035 0.15� 0.16� 0.028 0.055
Reg 1b fecal,
μg/g
0.16� 0.16� 0.10 0.015 0.16� 0.11 0.10 0.082
The following were studied as continuous variables: Counts of all positive pathogens, counts of positive bacteria, counts of positive protozoa, counts of positive viruses
and all biomarker concentrations.
Note: Values are Pearson correlation coefficients.
���p-value<0.0001
��p-value<0.001
�p-value<0.05.
Abbreviations: Flagellin = flic; Immunoglobulin = Ig; Lipopolysaccharide = LPS; alpha glycoprotein = AGP; C-reactive protein = CRP; Myeloperoxidase = MPO;
Neopterin = NEO; regenerating gene 1 beta = Reg 1b, change in length-for-age Z scores over the first 18 months of life = ΔLAZ. ¥Biomarkers measured were indicative
of systemic inflammation, bacterial translocation, enteric inflammation, or intestinal regeneration (left column indicates which biomarkers fall into each category).
https://doi.org/10.1371/journal.pone.0221095.t002
Enteropathogens and linear growth decline in EED
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In our study, we found that Campylobacter infection at 6 months of age had a negative effect
on future LAZ at nominal significance level and the effect became marginally after FDR adjust-
ment (Table 3). Campylobacter infection has been linked to inflammation and disruption of
the gut barrier functions [27], and with reduced weight gain in developing nations [28]. Addi-
tionally, the GEMS study, which focused on characterizing the burden of diarrheal disease in
Asia and Africa, identified Campylobacter as an important contributor to the diarrheal disease
burden with regional importance in Pakistan, Bangladesh and India [29]. Since the GEMS
study focused on diarrheal episodes, it is interesting to observe an association of Campylobac-
ter with asymptomatic children with linear growth faltering. We also found that Campylobac-
ter infection was associated with an increased expression of fecal MPO and to some extent
increase in Reg1b, a marker of enterocyte regeneration. Although both MPO and NEO have
previously shown to be highly associated with intestinal inflammation as well as growth failure
in children [20, 30, 31]. Our study did not identify any correlation between the presence of
Campylobacter with NEO per se. In light of prior research, it is clear that Campylobacter is a
pathogen of emerging importance and is involved in the causal pathway of environmental
enteropathy in developing countries.
The presence of Cryptosporidium and Giardia at 6 months showed negative decline in
LAZ (range -0.3 to -0.5) in the first 18 months of life, which was also supported by other
Table 3. The association of selected enteropathogens [at 6 (n = 272) and 9 (n = 271) months] with changes in LAZ scores over the first 18 months of life.
Enteropathogens at 6 months Enteropathogens at 9 months
p-values p-values
β for ΔLAZ SE nominal FDR-adjusted β for ΔLAZ SE nominal FDR-adjusted
Adenovirus 40/41 -0.05 0.25 0.856 0.856 -0.11 0.19 0.599 0.982
Astrovirus -0.38 0.19 0.046 0.116 0.07 0.21 0.725 0.982
Bacteroides fragilis 0.33 0.21 0.121 0.192 -0.08 0.18 0.681 0.982
Campylobacter jejuni/coli -0.36 0.16 0.025 0.091 -0.15 0.15 0.294 0.874
Campy_pan -0.36 0.15 0.014 0.090 -0.10 0.14 0.455 0.982
Cryptosporidium -0.45 0.20 0.028 0.091 -0.004 0.15 0.982 0.982
Cyclospora 0.26 0.66 0.688 0.688 0.44 0.36 0.228 0.874
EAEC -0.21 0.15 0.180 0.225 -0.14 0.17 0.420 0.982
EIEC Shigella -0.41 0.31 0.191 0.225 -0.03 0.24 0.902 0.982
EPEC -0.004 0.14 0.979 0.979 0.003 0.14 0.982 0.982
ETEC_LT -0.03 0.16 0.842 0.842 0.23 0.16 0.146 0.788
ETEC _STh -0.54 -1.6 0.107 0.192 0.06 0.27 0.820 0.982
ETEC_STp -0.05 0.27 0.846 0.846 -0.37 0.27 0.158 0.788
Enterocytozoon bieneusi 0.65 0.33 0.054 0.116 -0.013 0.21 0.951 0.982
Enterovirus -0.17 0.16 0.278 0.301 -0.11 0.16 0.517 0.982
Giardia -0.57 0.23 0.013 0.090 -0.36 0.19 0.055 0.546
Norovirus GI&II -0.22 0.15 0.133 0.192 -0.29 0.15 0.050 0.546
Rotavirus 0.21 0.26 0.426 0.426 -0.13 0.33 0.702 0.982
STEC Stx1 stx2 0.30 0.44 0.494 0.494 0.10 0.32 0.748 0.982
Sapovirus -0.14 0.25 0.565 0.565 -0.16 0.15 0.306 0.874
Notes: This regression model has been described in the Methods section as Model 1: ΔLAZ (18mo-birth) = β0 + β1 pathogen + β2 antibiotics + ε. The β1 is the estimated
effect of each pathogen obtained from a linear regression model using ΔLAZ score as the dependent variable (continuous) and the presence of each pathogen
(categorical) as the independent variable, adjusting for the antibiotic use (categorical variable) at 6 or 9 months. ΔLAZ refers to the change in length-for-age Z scores
over the first 18 months of life. Nominal p-values were directly estimated from the regression, while FDR-adjusted p-values were calculated using Proc MULTTEST in
SAS to account for multiple comparisons.
https://doi.org/10.1371/journal.pone.0221095.t003
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malnourished cohorts [32] [33]. Early infection of children with Cryptosporidium and Giardia
at 6 months of age is associated with linear growth faltering. The presence of the above patho-
gens was associated with a significant decline in LAZ (range -0.3 to -0.5) in the first 18 months
of life [11, 34]. In the GEMS study, Cryptosporidium infection was ranked among top three
pathogens associated with linear growth in children with less-severe diarrhea (LSD) and mod-
erate-to-severe diarrhea (MSD) as per GEMS definition [11, 34]. Additionally, Giardia infec-
tion has also been associated with intestinal permeability, malabsorption [33], and poor linear
growth, as hallmark features of EED [33, 35]. Furthermore, Berkman et al studied the effect of
Giardia infection on malnutrition and cognitive development in older children, as an impor-
tant outcome of EED [36] [37].
Among etiologies of diarrheal infection, Norovirus has been identified as an important
enteropathogen of malnutrition and growth faltering in the Mal-ED and GEMS studies [29,
Table 4. The association of select enteropathogens at 6 months (n = 272) with levels of specific biomarkers¥ at 6 months.
Enteropathogens Biomarkers at 6 months
Anti-flic IgA MPO Reg1b Serum Reg1b fecal
β SE p-value β SE p-value β SE p-value β SE p-value
Aeromonas -0.037 0.083 0.6540 -3939.221 10181.900 0.6992 -42.499 68.685 0.5366 -25.243 107.376 0.8143
Bacteroides fragilis 0.046 0.032 0.1521 -1370.069 3815.262 0.7198 48.266 26.182 0.0664 -20.334 40.886 0.6194
C. difficile 0.162 0.095 0.0888 15637.007 11575.970 0.1779 39.208 78.085 0.6160 -138.291 122.126 0.2586
Campylobacter -0.038 0.021 0.0750 7751.217 2608.554 0.0032� 5.972 17.717 0.7363 47.283 27.842 0.0907
EAEC 0.010 0.023 0.6525 3825.984 2765.798 0.1678 -1.241 18.999 0.9480 -32.145 29.305 0.2737
EIEC Shigella 0.000 0.048 0.9943 1174.943 5827.794 0.8404 66.294 39.374 0.0935 105.623 61.463 0.0869
EPEC 0.026 0.022 0.2287 -3996.395 2666.754 0.1352 51.733 18.301 0.0051� 7.466 28.322 0.7923
ETEC LT 0.061 0.025 0.0140 7089.216 3015.043 0.0195� 34.956 20.396 0.0878 30.101 31.852 0.3456
ETEC ST -0.107 0.050 0.0343� -1404.007 6136.554 0.8192 240.406 41.390 <0.0001� 54.556 64.725 0.4001
H. pylori -0.096 0.164 0.5576 -22212.603 20006.355 0.2679 -64.679 134.924 0.6321 -91.621 211.046 0.6646
STEC stx1 & stx2 -0.201 0.064 0.0020� -5795.417 7852.027 0.4611 -72.567 52.976 0.1720 48.500 82.830 0.5587
Cryptosporidium 0.017 0.031 0.5801 143.496 3779.297 0.9697 42.626 28.721 0.1390 6.316 38.985 0.8714
Cyclospora 0.009 0.101 0.9301 -12792.821 12445.159 0.3049 58.113 91.815 0.5273 -175.403 128.178 0.1724
E. bieneusi 0.089 0.049 0.0673 -7183.708 5992.814 0.2317 12.197 44.231 0.7830 -41.989 64.349 0.5146
Giardia 0.054 0.021 0.0091� 3249.669 2533.286 0.2007 11.925 18.871 0.5280 72.198 26.394 0.0067�
Trichuris 0.001 0.165 0.9960 7909.737 20352.996 0.6979 -25.837 150.156 0.8635 -95.863 209.633 0.6478
Adenovirus 40/41 0.052 0.025 0.0399� -5678.013 3073.041 0.0658 45.478 23.272 0.0518 6.561 33.448 0.8446
Astrovirus 0.093 0.028 0.0008� 6102.398 3371.487 0.0714 13.766 25.397 0.5883 21.750 36.408 0.5508
Enterovirus 0.029 0.023 0.2015 3258.000 2795.368 0.2449 -47.315 21.170 0.0263� -20.881 30.004 0.4871
Norovirus GI, GII 0.036 0.021 0.0902 -1707.927 2582.729 0.5090 21.473 19.581 0.2738 31.404 27.746 0.2588
Rotavirus 0.035 0.037 0.3492 -5967.456 4572.710 0.1930 6.533 34.087 0.8482 -36.507 50.040 0.4663
Sapovirus 0.012 0.037 0.7378 -8799.921 4399.301 0.0465� -34.222 32.823 0.2981 6.039 46.964 0.8978
Note: This regression model has been described in the methods section as Model 2: Biomarker = β0 + β1 pathogen1 + β2 pathogen2 + . . . + βkpathogenk + βk+1 antibiotics
+ ε. βk is estimated effects of each pathogen obtained via a multiple linear regression model using the levels of biomarkers at 6 months as the dependent variable
(continuous) and the presence of each pathogen (categorical) as multiple independent variables. Antibiotic use (categorical variable) was included in the model as a
covariate.
���p-value<0.0001
��p-value<0.001
�p-value<0.05
Abbreviations: Flagellin = flic; Immunoglobulin = Ig; alpha glycoprotein = AGP; C-reactive protein = CRP; Myeloperoxidase = MPO; regenerating gene 1 beta = Reg1b
¥Biomarkers were indicative of systemic inflammation (CRP, AGP), bacterial translocation (anti-flic IgA), enteric inflammation (MPO), and intestinal regeneration
(Reg1b). The specific biomarkers included in this analysis were chosen because they significantly correlated with increasing pathogen counts at either 6 or 9 months
https://doi.org/10.1371/journal.pone.0221095.t004
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38]. Association of Norovirus and malnutrition is well established in murine model [39],
which may involve in modulation of tight junctions. In asymptomatic children with non-diar-
rheal stools, we did not find any significance of Norovirus on growth decline.
Increased pathogen count at 6 months also correlated with increase in anti-flic IgA levels,
an activation signal of innate immune response initiated by recognition of PAMPS (bacterial
flagellin) by Toll-like receptor 5 (TLR5), which activates downstream signaling pathway of
NF-kB regulated pro-inflammatory proteins. Bacterial flagellin is thought to be involved in
mucosal damage by targeting the basolateral surface of intestinal cells. [40, 41]. In our cohort,
we also found an association of antibodies against Anti-flic IgA with biomarkers of intestinal
inflammation and regeneration (MPO and Reg1b) [15]. Anti-flic IgA antibodies are therefore
considered a marker of translocation of flagellin-producing bacteria in blood [42].
Reg1b is a marker of enterocyte regeneration [43], which is associated with presence of
enterotoxigenic E. coli (ETEC) and Campylobacter infections at 6 and 9 months of age. Reg 1b
is a predictor of childhood stunting in Bangladeshi cohort [44]. Reg1β did not show a direct
relationship with linear growth faltering previously shown in this cohort [16]
We found that biomarkers of systemic inflammation, CRP, AGP and Ferritin, were not sig-
nificantly associated with overall burden of pathogens. On stratification, only protozoal infec-
tion at 9 months was moderately correlated with inflammatory markers, which indicates the
process of cellular damage and activation of immune mechanism. Such an increase in CRP has
been reported in travelers in tropics with protozoal infections [45]. In the acute phase of bacte-
rial diarrhea in Egyptian children, CRP was identified as marker of acute inflammation along
with Trem-1 and Procalcitonin [46]. The lack of CRP elevation in our study could reflect low
frequency of diarrhea in our children and indicates that they had probably passed the acute
phase of infection. An early rise in CRP and AGP have been associated with stunting in Zimba-
bwean infants and, as recently reported, with future stunting in this Pakistani cohort [18, 47].
Furthermore, a recent South Indian study evaluated asymptomatic carriage of enteropatho-
gens in children from two communities to study the effect of the environment on pathogen
burden and corresponding changes in inflammatory biomarkers [48]. In comparison to this
study, our study had a longitudinal study design for both biological sample collection and
anthropometric measurements. We also analyzed a larger panel of pathogens and wider array
of systemic/gut inflammatory biomarkers. Our analyses also focused on association of entero-
pathogen with changes in LAZ and varying levels of biomarkers.
Strengths of our study include: a) longitudinal follow-up with prospective repeated measures
of growth; b) use of a highly sensitive platform that has shown superior sensitivity in the detec-
tion of enteropathogens as already been utilized in the MAL-ED [23] and GEMS cohorts [11],
and c) co-existence of enteropathogens and EED biomarkers spanning gut-specific, systemic,
and mucosal inflammatory responses. Our study is limited with a) censoring of data at 18
months of age, thus limiting follow-up beyond 18 months to be able to ascertain the persistence
of infection and outcome on long term growth and cognition; b) we evaluated growth faltering
as changes in the linear slope of z scores, and thus were limited in using growth faltering at the
first 18 months of life as a clinical proxy of EED; and lastly c) we were unable to collect dietary
information in this cohort to correlate these important findings and d) multiple comparison of
pathogens and biomarker data in regression model lost some of the significance after correction
for FDR. Also, the growth modelling did not account for early and later stunting in this cohort.
Conclusion
In conclusion, childhood infection with increasing numbers of pathogens is associated with an
increase in biomarkers of inflammation and intestinal permeability with a decrease in linear
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growth. Moreover, specific pathogens, such as Campylobacter, Cryptosporidium and Giardia
seem to play a key role in such associations with growth and increase in inflammatory bio-
markers which may be involved in the process of EED. With the advent of a combination vac-
cine against Shigella and enterotoxigenic E. coli, prevention of enteric infections may reduce
the risk of enteric infections that seem to play a critical role in the pathogenesis of EED.
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